Skip to main content

Table 3 Characteristics of participants who completed the phone survey (n = 119)

From: Available but inaccessible: patient experiences during the first 2 years of a primary care-based medical cannabis program at an academic medical center

 

n = 119

Age (years), mean (SD)

56.2 (12.1)

Gender: female, n (%)*

83 (69.7)

Main symptom targeted, n (%)

 

 Pain

101 (85.6)

 Anxiety

7 (5.9)

 Insomnia

3 (2.5)

 Other

7 (5.9)

Ever purchased medical cannabis, n (%)

87 (73.1)

Purchased medical cannabis more than once, n (%)

63 (52.9)

Use of unregulated cannabis, n (%)

52 (43.7)

Reason for not purchasing medical cannabis (n = 56), n (%)

 

 Price

28 (50)

 Convenience of dispensary locations

14 (25)

 Ineffectiveness

6 (10.7)

 Problems with registration

4 (7.1)

 Perceived effectiveness of medical cannabis (n = 86), mean (SD)

6.9 (2.9)

Preferred route of administration of medical cannabis (n = 86), n (%)

 

 Oil

55 (64)

 Vape

32 (37.2)

 Capsule

24 (27.9)

 Other

10 (11.8)

  1. *Proportion of gender is significantly different than the whole cohort (n = 562)